Real-time enrollment status for this clinical high risk for psychosis (chr) clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 7:48 AM UTC
| NCT Number | NCT07226895 |
| Recruiting Status | Recruiting |
| Condition | Clinical High Risk for Psychosis (CHR) |
| Phase | Clinical Trial |
| Target Enrollment | 150 participants |
| Active Locations | 15 sites in the US |
| Sponsor | Monument Therapeutics Limited |
| Last Updated on CT.gov | June 8, 2026 (Jun 8, 2026) |
As of July 13, 2026: Clinical trial NCT07226895 is currently recruiting participants. This clinical trial study for clinical high risk for psychosis (chr) is actively seeking new participants at 15 locations across the United States. The study is sponsored by Monument Therapeutics Limited. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07226895 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 15 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07226895 was last updated Jun 8, 2026 (June 8, 2026). HelloStudys verifies this status automatically.